KERATOCONUS

This early study tests whether TN-001 eye drops are safe and can stop keratoconus from getting worse. About 20 adults with progressive keratoconus will use the drops twice daily for 3-6 weeks. Researchers will monitor side effects and measure changes in the cornea and vision.

This study tests whether a procedure called corneal collagen crosslinking can stop keratoconus from getting worse. Keratoconus is a condition where the cornea (the clear front part of the eye) becomes thin and bulges into a cone shape, causing blurry vision. The treatment uses sp…

This study compares an artificial intelligence (AI) system called AEYE to a human eye specialist in diagnosing keratoconus (a condition that thins the cornea) and deciding if someone is a good candidate for laser eye surgery. Researchers will use 50 real patient cases to see if t…

This study tests a tiny steroid-releasing implant called Dextenza against standard steroid eye drops for managing inflammation after corneal crosslinking surgery for keratoconus. About 20 people aged 13 and older with progressive keratoconus will take part. The goal is to see if …

This study looks at 50 people with keratoconus, a disease that thins and bulges the cornea, causing blurry vision. Researchers use painless eye tests (electrophysiology) to measure how well the retina and brain respond to light. The goal is to see if these tests can help doctors …

This study uses a special light-based technique called Brillouin microscopy to measure how stiff or weak the cornea is in people with keratoconus, a condition that thins and bulges the cornea. Researchers will also look at how the cornea changes after treatments like cross-linkin…